NASDAQ · CAMT

Camtek Ltd.

$147.79 -$7.40 (-4.77%) 1D After hours

Key Metrics

$7.24B
Market cap
142.75×
P/E · TTM
$496.07M
Revenue · TTM
$50.72M
Net income
EPS · TTM $1,038.05
Dividend yield
Free cash flow $127.48M
Beta · 1Y 2.54
EBITDA · TTM $64.11M
Gross margin 50.5%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 7
    From its May 11 high, the share price fell 36%.

    Peak close $207.46 on May 11; trough close $133.26 on Jul 7. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -36%
  • Jun 2
    The stock moved +15.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 2
  • May 12
    The stock moved -15.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 12

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$7.24B
Enterprise value
Shares outstanding46.7M
52-wk range$75.75 – $215.99
Avg volume · 20D358.3K
Net cash
Book value / share$12,627.20
ExchangeNASDAQ
About Camtek Ltd.
IPO dateJul 28, 2000
Employees709

Camtek Ltd is engaged in the manufacturing of metrology and inspection equipment and software solutions for the semiconductor industry.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E142.75
P/S14.60
P/FCF56.80
EV/EBITDA
EV/Sales
Graham №$17,173.27

Profitability

Gross 50.5%
Operating 10.5%
Net 10.2%
FCF 25.7%
ROE / ROIC 8.7% · 14.1%

Financial Health

Current ratio8.35
Quick ratio7.31
Debt / equity
Debt / EBITDA
Net cash
Working capital$789.57M

Cash Flow · TTM

Operating CF $141.87M
Capex −$14.40M
Free cash flow $127.48M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

8.5
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$17,173.27 vs $147.79
Trades below classic defensive value — Graham-cheap
Fundamentals through 2025-06-30 · computed by TickerWolf from SEC filings